Next, we evaluated the possible ferroptotic ROS‐activated pathways in HNSCC cells by co‐treatment with FIN56 and different inhibitors for inflammatory signal pathways, including a STAT3 inhibitor, a STAT1 inhibitor, and an NF‐κB inhibitor. This evidence concerns the gene STAT1 and head and neck squamous cell carcinoma.